{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T18:25:32Z","timestamp":1693679132291},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.lungcan.2012.12.008","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T21:01:32Z","timestamp":1359234092000},"page":"39-44","source":"Crossref","is-referenced-by-count":5,"title":["Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?"],"prefix":"10.1016","volume":"80","author":[{"given":"Jenette","family":"Creaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Dare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Demelker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur William","family":"Musk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce W.S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2012.12.008_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-642-10858-7_3","article-title":"Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities","volume":"188","author":"Dunn","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0015","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0025","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1055-9965.EPI-10-0346","article-title":"Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma","volume":"19","author":"Creaney","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2490-9-14","article-title":"A systematic review of the diagnostic accuracy of prostate specific antigen","volume":"9","author":"Harvey","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.07-0013","article-title":"Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma","volume":"132","author":"Creaney","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0040","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","article-title":"Mesothelin variant 1 is released from tumor cells as a diagnostic marker","volume":"15","author":"Hellstrom","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0050","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","article-title":"Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma","volume":"96","author":"Scholler","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 3","key":"10.1016\/j.lungcan.2012.12.008_bib0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0060","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","author":"Rump","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.lungcan.2011.01.011","article-title":"Mesothelin and kidney function \u2013 analysis of relationship and implications for mesothelioma screening","volume":"73","author":"Boudville","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-1759(98)00107-0","article-title":"A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples","volume":"217","author":"Steindl","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0075","article-title":"Development of a CA125\u2013mesothelin cell adhesion assay as a screening tool for biologics discovery","author":"Scholler","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0085","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1074\/jbc.M806776200","article-title":"A binding domain on mesothelin for CA125\/MUC16","volume":"284","author":"Kaneko","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","article-title":"Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy","volume":"68","author":"Hassan","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0095","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/ijc.25557","article-title":"A novel high-affinity human monoclonal antibody to mesothelin","volume":"128","author":"Ho","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7150\/jca.2.280","article-title":"HN125: a novel immunoadhesin targeting MUC16 with potential for cancer therapy","volume":"2","author":"Xiang","year":"2011","journal-title":"J Cancer"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1470-2045(07)70357-1","article-title":"Benign causes of increased serum CA-125 concentration","volume":"8","author":"Sevinc","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0120","first-page":"3129","article-title":"Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells","volume":"17","author":"Zeimet","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0125","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/MPA.0b013e318221bed8","article-title":"Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma","volume":"40","author":"Einama","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.lungcan.2012.12.008_bib0130","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-3204","article-title":"Post mortem findings of malignant pleural mesothelioma: a two-centre study of 318 patients","author":"Finn","year":"2012","journal-title":"Chest"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212006538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212006538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T05:31:08Z","timestamp":1539927068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500212006538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0169500212006538"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2012.12.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}